Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 972
JAK/STAT Mediated Inhibition of Mir-23a~24-2~27a Cluster Potentiates Activation of CD14+ Monocytes in Treatment-Resistant RA
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?- 9:00AM-11:00AM
-
Abstract Number: 1575
JMJD3 Epigenetically Regulate Ankylosing Spondylitis Inflammation through Th17 Differentiation
Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II- 9:00AM-11:00AM
-
Abstract Number: 1015
Key Genes and Pathways between Rheumatoid Arthritis and Osteoarthritis By Integrative Genome-Wide Gene Expression Profiling Analysis
Genetics, Genomics and Proteomics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1459
Lack of Drug-Drug Interaction between Filgotinib, a JAK-1 Selective Inhibitor, and a Representative Hormonal Contraceptive Medication, Levonorgestrel/Ethinyl Estradiol
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1304
Lack of Uptake of Prophylactic Human Papilloma Virus (HPV) Vaccination Among Women with SLE in Saginaw Valley, a High Risk Population
Reproductive Issues in Rheumatic Disorders Poster- 9:00AM-11:00AM
-
Abstract Number: 1089
Large Variations in Tuberculosis Testing for New Biologic Users with Rheumatoid Arthritis Among Providers in the RISE Registry
Measures and Measurement of Healthcare Quality Poster I- 9:00AM-11:00AM
-
Abstract Number: 1120
Less Than Half of Patients Treated with High-Dose Allopurinol Reach Serum Uric Acid Target
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 1644
Less Than Seven Hours of Sleep per Night Is Associated with Transitioning to Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 974
Leucine-Rich α-2 Glycoprotein Promotes Lung Fibrosis By Modulating TGF-β Signaling in Fibroblasts
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?- 9:00AM-11:00AM
-
Abstract Number: 1208
Levels of Serum Biomarkers from a Two-Year Multicentre Trial Are Associated with Treatment Response on Knee Osteoarthritis Cartilage Loss As Assessed By MRI: An Exploratory Study
Osteoarthritis – Clinical Aspects Poster I: Clinical Trials and Interventions- 9:00AM-11:00AM
-
Abstract Number: 1721
Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGFβ-Driven Fibrotic Diseases
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1115
Long-Term Adherence to Urate-Lowering Therapy in Gout: Do Not Blame on the Patients
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 1498
Long-Term Cohort of Patients with a Clinical Diagnosis of Sjogren’s Syndrome: Activity Index and Patient Reported Outcome Performance
Sjögren's Syndrome Poster II: Clinical Research- 9:00AM-11:00AM
-
Abstract Number: 1563
Long-Term Effects of TNF-Alpha Inhibitors on Bone Mineral Density and the Incidence of Vertebral Fractures in Patients with Ankylosing Spondylitis